Evidence map›Paper›PMID 28937968›Full record

ArticleZeitschrift fur Naturforschung. C, Journal of biosciences2018

Diverse bioactive compounds from Sarcophtyton glaucom: structure elucidation and cytotoxic activity studies.

Mohamed Shaaban, Ali M El-Hagrassi, Mohamed A Abdelghani, Abeer F Osman

Abstract read
PubMed Publisher
In one paragraph

Article in Zeitschrift fur Naturforschung. C, Journal of biosciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohamed ShaabanChemistry of Natural Compounds Department, Division of Pharmaceutical Industries, National Research Centre, El-Behoos St. 33, Dokki-Cairo 12622, Egypt.ORCID 0000-0001-9281-2505
Ali M El-HagrassiDepartment of Phytochemistry and Plant Systematics, Division of Pharmaceutical Industries, National Research Centre, El-Behoos St. 33, Dokki-Cairo 12622, Egypt.
Mohamed A AbdelghaniRed Sea Marine Parks, P.O. Box 363, Hurghada, Red Sea, Egypt.
Abeer F OsmanChemistry of Natural Compounds Department, Division of Pharmaceutical Industries, National Research Centre, El-Behoos St. 33, Dokki-Cairo 12622, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemical investigation of the Red Sea soft coral Sarcophyton glaucom collected at the coasts of Hurghada, Egypt, led to the isolation of one new naturally occurring 4-oxo-1,1′-pentanoic acid anhydride (1), along with four diterpenes; sarcophinone (2a), 8-epi-sarcophinone (2b), (+)-7α,8β-dihydroxydeepoxysarcophine (3), sinumaximol G (4), (+)-sarcophine (5), sesquiterpene; prostantherol (6), sterol; 3β,24S-ergost-5-en-ol (7) and hexadecanoic acid. The structures of the obtained compounds were established using diverse spectroscopic techniques including 1D and 2D NMR and HRMS. Biologically, in vitro cytotoxic activities of diterpenes 2–5 and prostantherol (6) were studied against the liver cancer HEPG2 cell line in comparison with the soft coral extract and doxorubicin as reference (IC50: 4.28 μg/mL). Compounds 2–6 exhibited potent–moderate cytotoxicity of IC50 between 9.97 μg/mL [for sinumaximol G (4)] and 17.84 μg/mL [for (+)-7α,8β-dihydroxydeepoxysarcophine (3)], whereas that for soft coral extract was determined at 24.71 μg/mL.

Indexed as

AnimalsAnthozoaAntineoplastic AgentsBiological FactorsCell ProliferationCell SurvivalDrug Screening Assays, AntitumorEgyptHep G2 CellsHumansInhibitory Concentration 50Molecular StructureTerpenesAntineoplastic AgentsBiological FactorsTerpenescytotoxic activityditerpenesSarcophyton glaucomsesquiterpene

Identifiers

PMID28937968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.